Amphista Therapeutics Raises $7.5m Series A Round to Advance Targeted Protein Degradation Assets in Cancer |
| April 07, 2020 | April 2020 Bond Updates |
|
GLASGOW, Scotland, April 7, 2020 /PRNewswire/ -- Amphista Therapeutics, a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body's natural processes to selectively and efficiently degrade and remove disease causing proteins, today announced the closing... |
| View more at: https://www.prnewswire.com:443/news-releases/amphista-therapeutics-raises-7-5m-series-a-round-to-advance-targeted-protein-degradation-assets-in-cancer-301035867.html |
| Related News |